A simple α-amide conjugate between the ω-3 essential fatty acid α-linolenate and the amino acid tyrosine that was prepared as a mechanism for enhancing CNS dopamine content by facilitated transport of the tyrosine precursor across the blood-brain barrier; increased CNS dopamine levels and exhibited an activity profile consistent with an anti-Parkinson’s therapeutic agent in experimental rat models of dopamine insufficiency.